Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: Potential applications for alloimmunized patients and rare blood challenges

Transfusion Medicine Reviews

Volumn 25, Issue 3, 2011, Pages 206-216

  Peyrard, Thierry ^a   Bardiaux, Laurent ^b   Krause, Claire ^c   Kobari, Ladan ^d   Lapillonne, Hélène ^e   Andreu, Georges ^f   Douay, Luc ^c,g  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Centre National de Référence Pour Les Groupes Sanguins   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d INSERM   (France)

^e CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIBODY; ERYTHROCYTE ANTIGEN;

ARTICLE; BLOOD BANK; BLOOD COMPATIBILITY; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP RHESUS SYSTEM; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELL SELECTION; COHORT ANALYSIS; CRYOPRECIPITATE; DISEASE REGISTRY; EMBRYONIC STEM CELL; ERYTHROCYTE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; GENOTYPE PHENOTYPE CORRELATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR REPROGRAMMING; NULL ALLELE; PLURIPOTENT STEM CELL; PREVALENCE; RETROSPECTIVE STUDY; RHESUS ALLOIMMUNIZATION; RHESUS IMMUNIZATION; SICKLE CELL ANEMIA; UMBILICAL CORD BLOOD;

ADULT; ADULT STEM CELLS; ANIMALS; BLOOD BANKS; BLOOD GROUPING AND CROSSMATCHING; BLOOD SPECIMEN COLLECTION; CELL DIFFERENTIATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; ISOANTIBODIES; PLURIPOTENT STEM CELLS;

EID: 79958806565     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.01.002     Document Type: Article

References (55)

1. Garratty G. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs. Transfus Med Rev 2004, 18:245-256.
2. Kruskall M.S., AuBuchon J.P., Anthony K.Y., et al. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion 2000, 40:1290-1298.
3. Winslow R.M. Red cell substitutes. Semin Hematol 2007, 44:51-59.
4. United Nations, Department of Economic and Social Affairs, Population Division (2007). World Population Prospects: The 2006 Revision, Highlights, Working Paper No. ESA/P/WP.202.
5. Neildez-Nguyen T.M., Wajcman H., Marden M.C., et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol 2002, 20:467-472.
6. Giarratana M.C., Kobari L., Lapillonne H., et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005, 23:69-74.
7. Migliaccio A.R., Whitsett C., Migliaccio G. Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol 2009, 16:259-268.
8. Douay L., Lapillonne H., Turhan A.G. Stem cells-A source of adult red blood cells for transfusion purposes: Present and future. Crit Care Clin 2009, 25:383-398.
9. Douay L., Giarratana M.C. Ex vivo generation of human red blood cells: a new advance in stem cell engineering. Methods Mol Biol 2009, 482:127-140.
10. Timmins N.E., Nielsen L.K. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009, 27:415-422.
11. Fujimi A., Matsunaga T., Kobune M., et al. Ex vivo large-scale generation of human red blood cells from cord blood CD34(+) cells by co-culturing with macrophages. Int J Hematol 2008, 87:339-350.
12. Miharada K., Hiroyama T., Sudo K., et al. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol 2006, 24:1255-1256.
13. Baek E.J., Kim H.S., Kim S., et al. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008, 48:2235-2245.
14. Kaufman D.S., Hanson E.T., Lewis R.L., et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001, 98:10716-10721.
15. Vodyanik M.A., Thomson J.A., Slukvin I.I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006, 108:2095-2105.
16. Qiu C., Hanson E., Olivier E., et al. Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 2005, 33:1450-1458.
17. Chadwick K., Wang L., Li L., et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003, 102:906-915.
18. Cerdan C., Rouleau A., Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 2004, 103:2504-2512.
19. Zambidis E.T., Peault B., Park T.S., et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood 2005, 106:860-870.
20. Kennedy M., D'Souza S.L., Lynch-Kattman M., et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007, 109:2679-2687.
21. Chang K.H., Nelson A.M., Wang L., et al. Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin. Blood 2006, 108:1515-1523.
22. Qiu C., Olivier E.N., Velho M., et al. Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood 2008, 111:2400-2408.
23. Ma F., Ebihara Y., Umeda K., et al. Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A 2008, 105:13087-13092.
24. Lu S.J., Feng Q., Park J.S., et al. Biological properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008, 112:4475-4484.
25. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
26. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
27. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
28. Choi K.D., Yu J., Smuga-Otto K., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009, 27:559-567.
29. Choi K.D., Vodyanik M.A., Slukvin I.I. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 2009, 119:2818-2829.
30. Feng Q., Lu S.J., Klimanskaya I., et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 2010, 28:704-712.
31. Lapillonne H., Kobari L., Mazurier C., et al. Red blood cells generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica 2010, 95:1651-1659.
32. Douay L., Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?. Transfus Med Rev 2007, 21:91-100.
33. Schonewille H., van de Watering L., Loomans D.S., et al. Anneke Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006, 46:250-256.
34. Schonewille H., van de Watering L., Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?. Transfusion 2006, 46:630-635.
35. Noizat-Pirenne F., Tournamille C., Bierling P., et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006, 46:1328-1333.
36. Bauer M.P., Wiersum-Osselton J., Schipperus M., et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007, 47:2066-2071.
37. Rapport annuel d'hémovigilance 2008, Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS). http://www.afssaps.fr/var/afssaps_site/storage/original/application/8cd23a5cc28ff824c5ea95e1974b6b19.pdf.
38. Walker R.H., Lin D.T., Hartrick M.B. Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989, 113:254-261.
39. Hoeltge G.A., Domen R.E., Rybicki L.A., et al. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995, 119:42-45.
40. Ahrens N., Pruss A., Mayer B., et al. Association between alloantibody specificity and autoantibodies to red blood cells. Transfusion 2008, 48:20-24.
41. Peyrard T., Pham B.N., Rouger P. The red blood cell antigen terminologies. Transfus Clin Biol 2009, 16:388-399.
42. Fluit C.R., Kunst V.A., Drenthe-Schonk A.M. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990, 30:532-535.
43. Peyrard T., Pham B.N., Le Pennec P.Y., et al. The rare blood groups: a public health challenge. Transfus Clin Biol 2008, 15:109-119.
44. Reesink H.W., Engelfriet C.P., Schennach H., et al. Donors with a rare pheno (geno) type. Vox Sang 2008, 95:236-253.
45. Peyrard T., Pham B.N., Le Pennec P.Y., et al. Transfusion of rare cryopreserved red blood cell units stored at -80°C degrees: the French experience. Immunohematology 2009, 25:13-17.
46. Nance S.T. How to find, recruit and maintain rare blood donors. Curr Opin Hematol 2009, 16:503-508.
47. Seltsam A., Wagner F.F., Salama A., et al. Antibodies to high-frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003, 43:1563-1566.
48. Peyrard T., Rouger P. Transfusion and obstetrical safety of people with a rare blood group. Hématologie 2010, 16:143-155.
49. Hemker M.B., Ligthart P.C., Berger L., et al. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999, 94:4337-4342.
50. Wagner F.F., Moulds J.M., Tounkara A., et al. RHD allele distribution in Africans of Mali. BMC Genet 2003, 4:14.
51. Price C.L., Boyd J.H., Watkins A.R., et al. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion 2006, 46:1388-1393.
52. Boulware L.E., Ratner L.E., Ness P.M., et al. The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. Transfusion 42; 2002, 669-678.
53. Veldhuisen B., van der Schoot C.E., de Haas M. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009, 97:198-206.
54. Flegel W.A. Rare gems: null phenotypes of blood groups. Blood Transfus 2010, 8:2-4.
55. Seifinejad A., Taei A., Totonchi M., Vazirinasab H., et al. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells. Biochem Biophys Res Commun 2010, 391:329-334.